E-nose Utility in the Diagnosis of Bacterial Infection in COPD

NCT01976117 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-09-08

No results posted yet for this study

Summary

Hypothesis: A commercial e-nose (Cyranose 320) is able to detect specific breathprints from patients with COPD and bacterial infection

Conditions

  • Pulmonary Disease, Chronic Obstructive (COPD)

Interventions

DEVICE

enose

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976117 on ClinicalTrials.gov